[Dose escalation in prostate cancer-standard dose versus dose escalation with simultaneous integrated boost to intraprostatic tumor formation: results from the FLAME Trial]
- PMID: 35037083
 - DOI: 10.1007/s00066-021-01892-0
 
[Dose escalation in prostate cancer-standard dose versus dose escalation with simultaneous integrated boost to intraprostatic tumor formation: results from the FLAME Trial]
Comment on
- 
  
  Focal Boost to the Intraprostatic Tumor in External Beam Radiotherapy for Patients With Localized Prostate Cancer: Results From the FLAME Randomized Phase III Trial.J Clin Oncol. 2021 Mar 1;39(7):787-796. doi: 10.1200/JCO.20.02873. Epub 2021 Jan 20. J Clin Oncol. 2021. PMID: 33471548 Clinical Trial.
 
References
Literatur
- 
    
- Dearnaley D, Syndikus I, Mossop H et al (2016) Conventional versus hypofractionated high-dose intensity-modulatedradiotherapyforprostatecancer: 5‑year outcomesoftherandomised, non-inferiority, phase 3 CHHiPtrial. Lancet Oncol 17:1047–1060 - DOI
 
 - 
    
- Catton CN, Lukka H, Gu CS et al (2017) Randomized trial of a hypofractionated radiation regimen forthe treatment of localized prostate cancer. J Clinoncol 35:1884–1890 - DOI
 
 - 
    
- Roach M, Moughan J, Lawton CAF et al (2018) Sequenceof hormonal therapy and radiotherapy fieldsize in unfavourable, localisedprostatecancer (NRG/RTOG 9413): long-term resultsof a randomised, phase 3 trial. Lancet Oncol 19:1504–1515 - DOI
 
 
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
